AtriCure, Inc. (ATRC) Stock Price, News, Quote & History - Yahoo Finance

3d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

AtriCure, Inc.

2mon ago, source: CNN

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio ...

AtriCure upgraded at Oppenheimer on valuation

on MSN ago, source:

AtriCure (ATRC) stock rises as Oppenheimer upgrades the company, citing attractive valuation compared to peers in the small-cap MedTech. Read more here.

Key Takeaways From AtriCure Analyst Ratings

16d ago, source:

In the assessment of 12-month price targets, analysts unveil insights for AtriCure, presenting an average target of $48.0, a ...

AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management

7d ago, source:

AtriCure (ATRC) unveils its cryoSPHERE+ cryoablation probe, which is intended to reduce freeze times and aid in postoperative ...

First Week of June 21st Options Trading For AtriCure (ATRC)

6d ago, source: Nasdaq

Investors in AtriCure Inc (Symbol: ATRC) saw new options begin trading this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ATRC ...

AtriCure to Announce First Quarter 2024 Financial Results

16d ago, source: Stockhouse

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...

Oppenheimer upgrades AtriCure stock on improved risk-reward

3d ago, source: Investing

On Tuesday, AtriCure Inc. (NASDAQ: ATRC), a company specializing in medical devices for cardiac disorders, received an upgrade from an analyst at Oppenheimer. The stock rating was raised from ...

AtriCure to Announce First Quarter 2024 Financial Results

15d ago, source: ADVFN

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management ...

Oppenheimer upgrades AtriCure stock on improved risk-reward

3d ago, source: Investing

On Tuesday, AtriCure Inc. (NASDAQ: ATRC), a company specializing in medical devices for cardiac disorders, received an upgrade from an analyst at Oppenheimer. The stock rating was raised from Perform ...